Drug Acquisition: Dealing With CAP Vendors May Be More Trouble Than It's Worth

Why This Topic Matters

CAP policy can affect how practices obtain and manage Part B drugs, the operational workload tied to vendor coordination, and patient access to therapy. Understanding the program’s administrative and logistical requirements helps practices evaluate whether participation is practical.

Article Sections

1. CMS and physician reactions to the Competitive Acquisition Program

   Overview of the Medicare drug acquisition program and reactions from physician organizations and practice leaders. The section frames the main operational and participation concerns discussed in the article.

2. Copayment issues, treatment interruptions, and returned medication

   Discussion of patient payment concerns, possible treatment disruption, and questions about handling unused or defective medication. The section focuses on the practical implications for offices and patients.

3. Administrative burden and implementation requirements

   Comments on staffing, vendor coordination, storage, reporting, and the time commitment practices may face. The section also notes CMS implementation timing and vendor qualification standards.

4. Emergency access and shipment timing

   Coverage of emergency procurement procedures and the logistics of splitting shipments or scheduling delivery. The section addresses timing expectations for drug arrival and immediate patient needs.